NCT00991016View on ClinicalTrials.gov

Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

PF-04805712

ascending single and multiple doses starting at 30 mg

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00991016 - Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers | Biotech Hunter | Biotech Hunter